
    
      Study Objectives:

      Primary: To assess safety of the Western Equine Encephalitis (WEE) Vaccine, Inactivated,
      TSI-GSD 210, lot 3-1-92.

      Secondary: To evaluate immunogenicity of the Western Equine Encephalitis (WEE) Vaccine,
      Inactivated, TSI-GSD 210, lot 3-1-92.
    
  